Publicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (194)

2025

  1. Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 275, Núm. 1, pp. 257-266

  2. Blood Progenitor Cell Mobilization Driven by TWEAK Promotes Neovascularization and Reduces Brain Damage in a Rat Model of Intracerebral Hemorrhage

    Antioxidants, Vol. 14, Núm. 5

  3. Blood-brain barrier leakage in renovascular hypertensive rats: A quantitative MRI analysis

    NeuroImage, Vol. 315

  4. Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease in Spain

    Neurologia, Vol. 40, Núm. 3, pp. 290-305

  5. Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis

    Neurology: Neuroimmunology and NeuroInflammation, Vol. 12, Núm. 2

  6. Correction to: Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline (Journal of Neurology, (2025), 272, 3, (246), 10.1007/s00415-024-12808-0)

    Journal of Neurology

  7. Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations

    Neurologia, Vol. 40, Núm. 2, pp. 171-181

  8. Dysphagia in Parkinson´s disease. A 5-year follow-up study

    Neurological Sciences, Vol. 46, Núm. 6, pp. 2637-2653

  9. Elevated Serum Levels of Acid Sphingomyelinase in Female Patients with Episodic and Chronic Migraine

    Antioxidants, Vol. 14, Núm. 2

  10. Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms

    Neurotherapeutics, Vol. 22, Núm. 2

  11. Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline

    Journal of Neurology, Vol. 272, Núm. 3

  12. Hyperthermia and Early Growth of Cerebral Infarct: The Potential Role of Blood–Brain Barrier Permeability

    Translational Stroke Research

  13. Hypometabolism and atrophy patterns associated with Niemann-Pick type C

    EJNMMI Research, Vol. 15, Núm. 1

  14. JNK1 in SF1 neurons regulates the central action of thyroid hormones on hepatic lipid metabolism

    Molecular Metabolism, Vol. 98

  15. Neuroprotective effect of small extracellular vesicle-mediated targeting of AMPKα2 in cerebral ischemia

    Metabolism: Clinical and Experimental, Vol. 167

  16. Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome

    JAMA Neurology

  17. Renin–Angiotensin System Autoantibody Network in Parkinson’s Disease Patients

    Antioxidants, Vol. 14, Núm. 6

  18. Serum angiotensin type-1 receptor autoantibodies and neurofilament light chain as markers of neuroaxonal damage in post-COVID patients

    Frontiers in Immunology, Vol. 16

  19. Serum levels of autotaxin reveal its role as a novel biomarker of migraine

    Headache, Vol. 65, Núm. 6, pp. 944-960

2024

  1. Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission

    npj Parkinson's Disease, Vol. 10, Núm. 1